Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.

NCT04662723 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

878

Enrollment

OTHER

Sponsor class

Conditions

Glomerulonephritis
Immunoglobulin A Nephropathy

Interventions

DRUG: Corticosteroid
DRUG: Renin-angiotensin sytem blockers
DRUG: Sodium-glucose cotransporter 2 inhibitor

Sponsor

Fondazione Schena

Collaborators

[object Object]